A Pragmatic Randomized Feasibility Trial of Influenza Vaccines-Reference-Cited by-同舟云学术

A Pragmatic Randomized Feasibility Trial of Influenza Vaccines

Published:2023-01-24 Issue:2 Volume:2 Page:
ISSN:2766-5526
Container-title:NEJM Evidence
language:en
Short-container-title:NEJM Evidence

Author:

Johansen Niklas Dyrby¹²,Modin Daniel¹²,Nealon Joshua³,Samson Sandrine⁴,Salamand Camille⁴,Loiacono Matthew M.⁵,Larsen Carsten Schade⁶,Jensen Anne Marie Reimer¹²,Landler Nino Emanuel¹²,Claggett Brian L.⁷,Solomon Scott D.⁷,Landray Martin J.⁸⁹,Gislason Gunnar H.¹¹⁰¹¹¹²,Køber Lars¹⁰¹³,Jensen Jens Ulrik Stæhr¹⁴,Sivapalan Pradeesh¹⁴,Vestergaard Lasse Skafte¹⁵,Valentiner-Branth Palle¹⁵,Krause Tyra Grove¹⁵,Biering-Sørensen Tor¹²

Affiliation:

1. Department of Cardiology, Copenhagen University Hospital–Herlev and Gentofte, Copenhagen

2. Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen

3. School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong

4. Sanofi, Lyon, France

5. Sanofi, Swiftwater, PA

6. Department of Clinical Medicine, Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark

7. Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston

8. Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Public Health, University of Oxford, Oxford, United Kingdom

9. Big Data Institute, University of Oxford, Oxford, United Kingdom

10. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen

11. The Danish Heart Foundation, Copenhagen

12. The National Institute of Public Health, University of Southern Denmark, Copenhagen

13. Department of Cardiology, Copenhagen University Hospital–Rigshospitalet, Copenhagen

14. Respiratory Medicine Section, Department of Medicine, Copenhagen University Hospital–Herlev and Gentofte, Copenhagen

15. Epidemiological Infectious Disease Preparedness, Statens Serum Institut, Copenhagen

Publisher

Massachusetts Medical Society

Reference37 articles.

1. The Efficacy of Influenza Vaccine in Elderly Persons

2. Influenza Vaccine Effectiveness in the 2011–2012 Season: Protection Against Each Circulating Virus and the Effect of Prior Vaccination on Estimates

3. Influenza Vaccine Effectiveness in the United States during the 2015–2016 Season

4. Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases (NCIRD). Influenza (Flu). People at higher risk of flu complications. Centers for Disease Control and Prevention. October 21 2021 (https://www.cdc.gov/flu/highrisk/index.htm).

5. European Centre for Disease Prevention and Control (ECDC). Seasonal Influenza Vaccines. Risk groups for severe influenza. European Centre for Disease Prevention and Control. October 21 2021 (https://www.ecdc.europa.eu/en/seasonal-influenza/prevention-and-control/vaccines/risk-groups).

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing higher-dose and single standard-dose influenza vaccines in preventing cardiovascular events: a meta-analysis with 68,713 patients;Public Health;2024-10

2. High-Dose vs Standard-Dose Influenza Vaccine in Chronic Kidney Disease;Journal of the American College of Cardiology;2024-09

3. The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 2021-22 influenza season;Clinical Microbiology and Infection;2024-08

4. Evidence base for yearly respiratory virus vaccines: Current status and proposed improved strategies;European Journal of Clinical Investigation;2024-07-30

5. The relative vaccine effectiveness of high-dose vs standard-dose influenza vaccines in preventing hospitalization and mortality: A meta-analysis of evidence from randomized trials;Journal of Infection;2024-07